Eastgate Biotech Corp Stock Price To Earnings To Growth

ETBIDelisted Stock  USD 0  0.00  0.00%   
Eastgate Biotech Corp fundamentals help investors to digest information that contributes to Eastgate Biotech's financial success or failures. It also enables traders to predict the movement of Eastgate Stock. The fundamental analysis module provides a way to measure Eastgate Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eastgate Biotech stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Eastgate Biotech Corp Company Price To Earnings To Growth Analysis

Eastgate Biotech's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition

Based on the latest financial disclosure, Eastgate Biotech Corp has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceuticals (which currently averages 0.0) industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.

Eastgate Price To Earnings To Growth Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eastgate Biotech's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eastgate Biotech could also be used in its relative valuation, which is a method of valuing Eastgate Biotech by comparing valuation metrics of similar companies.
Eastgate Biotech is currently under evaluation in price to earnings to growth category among its peers.

Eastgate Fundamentals

About Eastgate Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Eastgate Biotech Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eastgate Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eastgate Biotech Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in Eastgate Stock

If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Transaction History
View history of all your transactions and understand their impact on performance